The American Society of Clinical Oncology recently (ASCO) issued a “rapid recommendation” to use Kimmtrak (ingredient: tebentafusp) to treat uveal melanoma.Kimmtrak won FDA approval early this year as the first uveal melanoma treatment.With the latest ASCO’s recommendation, Kimmtrak became the stand
One in five students in elementary, middle, and high schools in Seoul were obese, and 30 percent of them were overweight in 2021, a government report showed.Rep. Shin Hyun-young of the Democratic Party released the Seoul Metropolitan Office of Education’s report on student health examination data be
HLB Therapeutics said Monday that it would simultaneously start clinical trials for neuroparalytic keratitis treatment in the U.S. and Europe, signing related contracts with a global contract research organization (CRO).Eye disease drugs usually require two repetitive clinical outcomes. However, HLB
Next&Bio and Korea Institute of Science and Technology (KIST)’s European Research Institute have signed a joint research agreement to register guidelines for the “OECD adverse outcome pathway (AOP) verification act” to replace animal testing with organoids.Under the accord, the institute will regist
Korean scientists have developed a multiple genetic detection platform that can precisely diagnose gastric cancer.The Korea Research Institute of Bioscience and Biotechnology (KRIBB) said Monday that its researchers developed a diagnostic platform that detects genetic markers within the blood with h
New Korean pharmaceutical companies are racing to develop botulinum toxin (BTX) to sell them in the U.S. and Europe instead of the saturated Korean market, industry officials said. Such companies include BioPlus, CKD Bio, Jetema, EuBiologics, and ATGC.On Thursday, BioPlus announced a 2.3 billion won
The government said Friday that it was not considering additional quarantine measures even after confirming the first case of BA.2.75, dubbed "Centaurus," the most contagious Omicron subvariant with greater immune-avoiding properties than BA.5.On Thursday, Korea confirmed the first BA.2.75 case from
Kangstem Biotech said Friday it reapplied for a phase 1/2a IND of Furestem-OA Kit Inj. for osteoarthritis treatment to the Ministry of Food and Drug Safety.The company reapplied for a phase 1/2a clinical IND about a month after it voluntarily withdrew its original investigational new drug applicatio
Severance Hospital has introduced an early recovery program for people who receive an artificial knee joint surgery by reducing their pains and shortening the recovery period, the hospital said Friday.Doctors consider artificial knee joint surgery for severe degenerative knee arthritis patients. The
Japanese pharmaceutical companies’ Korean offshoots recorded low growth in 2021, according to their audit reports.The audit reports showed that the combined sales of the nine Japanese drugmakers’ Korean offshoots stood at 1.44 trillion won ($1 billion) last year, marking an increase of a mere 1.4 pe
GC Wellbeing said on Friday that it signed a technology transfer contract with Japan's Healthy Navi for its functional raw material Green Cera-F, a honey suckle bud extract.Green Cera-F is a raw material that has been recognized by the Ministry of Food and Drug Safety for its functionality that can
The government is wielding excessive power to lower drug prices without recognizing the values of innovative medicines, an expert said.Kim Sung-ju, an expert advisor for Lee & Ko’s Healthcare Practice Group, published an article in the Korea Pharmaceutical and Bio-Pharma Manufacturers Association’s
Bayer Korea said it would continue marketing Nebido, its long-acting injectable for males with testosterone deficiency, in the country, although its headquarters handed over the drug’s global rights to Grünenthal, a German pharmaceutical company.Grünenthal has picked up the global rights for the dru
Deep Bio said Friday that its deep learning-based prostate cancer pathology image analysis software, DeepDx-Prostate Pro, was selected as the Public Procurement Service's (PPS) innovative prototype (Fast Track II) in the bio-health area.To improve public services and innovate technology, the PPS des
Korea saw a trade surplus in vaccines for humans for the first time in the first half of this year, raising expectations for further growth of the vaccine industry.According to a report on exports and imports of human vaccines and diagnostic agents, published by the Korea Biotechnology Industry Orga
GenScript ProBio signed a memorandum of understanding with DAAN Bio Therapeutics to cooperate to discover and develop innovative drugs on Thursday.Through this MOU, GenScript ProBio and DAAN agreed to strengthen their cooperation, specifically in the cell and gene therapy (CGT) and biologics field.T
The U.S. FDA put off a decision on whether to approve tislelizumab, anti-PD-1 immunotherapy developed by BeiGene and Novartis, due to Covid-19-related travel restrictions.BeiGene, the Chinese pharmaceutical firm, said on Thursday that the FDA deferred a decision on approval for tislelizumab as a sec
The Research Investment for Global Health Technology Fund (RIGHT Fund) committed an additional 4 billion won ($3 million) to support four newly selected research projects concerning infectious diseases in the first half of 2022.The four recipients of the additional grants are CHA Vaccine Institute,
On Thursday, quarantine officials detected the first case of BA.2.75, dubbed “Centarus,” the most contagious Omicron subvariant with greater immune-avoidance properties than BA.5.BA.2.75, first sequenced in India in May, has been found in about 10 countries, including the U.S., Australia, and German
Wells Bio said Thursday that it has obtained an export license for its new pneumonia molecular diagnostic kit, “careGENE Pneumonia detection kit.”The kit is an in vitro diagnostic medical device that helps diagnose pneumonia infection. It detects the nucleic acid of pneumonia in sputum and nasophary